Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mechta

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Oncogene|October 1, 1990
Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotypeM Castellazzi, J P Dangy, F Mechta, et al.
Oncogene|September 27, 2016
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patientsS Lefort, A Thuleau, Y Kieffer, et al.
Molecular and Cellular Biochemistry|March 1, 2024
YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancerS Brosseau, P Abreu, C Bouchez, et al.
Oncoimmunology|August 21, 2019
A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancerL Faucheux, M Grandclaudon, M Perrot-Dockès, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Oncogene|October 1, 1990
Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotypeM Castellazzi, J P Dangy, F Mechta, et al.
Oncogene|September 27, 2016
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patientsS Lefort, A Thuleau, Y Kieffer, et al.
Molecular and Cellular Biochemistry|March 1, 2024
YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancerS Brosseau, P Abreu, C Bouchez, et al.
Oncoimmunology|August 21, 2019
A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancerL Faucheux, M Grandclaudon, M Perrot-Dockès, et al.
Pageof 2